MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
AN2 Therapeutics, Inc. (NASDAQ: ANTX)*
Organization & Developments: AN2 Therapeutics
Parents
AN2 Therapeutics, Inc. (NASDAQ: ANTX)*
Children
2022: AN2 Therapeutics Files For U.S. IPO_seekingalpha.com
2022: NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8
Focused on advancing its first product candidate, epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial (NTM) lung disease.
Jumps
Finance & Acquisitions: AN2 Therapeutics
Key People: AN2 Therapeutics